Westmount Partners, LLC
Position in NTHI — Neonc Technologies Holdings, Inc.
CIK 2051491
LOS ANGELES, CA
Position in NTHI
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$893,216
+$589,543 QoQ
Shares Held
197,178
+355.2% QoQ
Ownership
0.760%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#4
of 20 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTHI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Westmount Partners, LLC holds $2,556,295 across 6 Biotechnology names. NTHI ranks #2 (34.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
12,961 | $1,027,677 | |
| 2 | NTHI |
Neonc Technologies Holdings, Inc.
This page
|
197,178 | $893,216 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,000 | $301,030 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,118 | $232,228 | |
| 5 | ALLO |
Allogene Therapeutics, Inc.
|
36,000 | $74,880 | |
| 6 | FATE |
Fate Therapeutics Inc
|
10,098 | $27,264 |
All Filings in NTHI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $893,216 | 197,178 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $303,673 | 43,320 | Shares | Sole | 2026-04-16 | |
| 2025-09-30 | $365,088 | 40,208 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $261,488 | 73,246 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $225,623 | 16,888 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||